Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-Π2 and NF-ΰB

Nature Medicine

Volumn 17, Issue 7, 2011, Pages 883-887

  Purkayastha, Sudarshana ^a   Zhang, Guo ^a   Cai, Dongsheng ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART HEMODYNAMICS; HYPERTENSION; HYPOTHALAMUS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; UPREGULATION;

MUS;

EID: 79960117277     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2372     Document Type: Article

References (39)

1. Schwartz, M.W. & Porte, D. Jr. Diabetes, obesity, and the brain. Science 307, 375-379 (2005).
2. Münzberg, H. & Myers, M.G. Jr. Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 8, 566-570 (2005). (Pubitemid 40594195)
3. Howard, J.K. & Flier, J.S. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 17, 365-371 (2006). (Pubitemid 44596259)
4. Osborn, J.W., Fink, G.D., Sved, A.F., Toney, G.M. & Raizada, M.K. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr. Hypertens. Rep. 9, 228-235 (2007). (Pubitemid 46900043)
5. Veerasingham, S.J. & Raizada, M.K. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br. J. Pharmacol. 139, 191-202 (2003). (Pubitemid 36760351)
6. Veerasingham, S.J., Sellers, K.W. & Raizada, M.K. Functional genomics as an emerging strategy for the investigation of central mechanisms in experimental hypertension. Prog. Biophys. Mol. Biol. 84, 107-123 (2004). (Pubitemid 38215208)
7. Campese, V.M. et al. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am. J. Physiol. Heart Circ. Physiol. 287, H695-H703 (2004). (Pubitemid 38955301)
8. Guyenet, P.G. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7, 335-346 (2006).
9. Wofford, M.R. & Hall, J.E. Pathophysiology and treatment of obesity hypertension. Curr. Pharm. Des. 10, 3621-3637 (2004). (Pubitemid 39386578)
10. Dampney, R.A. et al. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin. Exp. Pharmacol. Physiol. 32, 419-425 (2005). (Pubitemid 40780269)
11. Haynes, W.G. Role of leptin in obesity-related hypertension. Exp. Physiol. 90, 683-688 (2005). (Pubitemid 41406056)
12. Rahmouni, K., Correia, M.L., Haynes, W.G. & Mark, A.L. Obesity-associated hypertension: new insights into mechanisms. Hypertension 45, 9-14 (2005). (Pubitemid 40066405)
13. Hall, J.E. et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 285, 17271-17276 (2010).
14. Shoelson, S.E. & Goldfine, A.B. Getting away from glucose: fanning the flames of obesity-induced inflammation. Nat. Med. 15, 373-374 (2009).
15. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006). (Pubitemid 46024993)
16. Lehrke, M. & Lazar, M.A. Inflamed about obesity. Nat. Med. 10, 126-127 (2004). (Pubitemid 38524875)
17. Petersen, K.F. & Shulman, G.I. Etiology of insulin resistance. Am. J. Med. 119, S10-S16 (2006).
18. Berg, A.H. & Scherer, P.E. Adipose tissue, inflammation and cardiovascular disease. Circ. Res. 96, 939-949 (2005). (Pubitemid 40712793)
19. Muoio, D.M. & Newgard, C.B. Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. 75, 367-401 (2006). (Pubitemid 44118037)
20. Schenk, S., Saberi, M. & Olefsky, J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002 (2008).
21. Duan, S.Z., Usher, M.G. & Mortensen, R.M. PPARs: the vasculature, inflammation and hypertension. Curr. Opin. Nephrol. Hypertens. 18, 128-133 (2009).
22. Harrison, D.G., Guzik, T.J., Goronzy, J. & Weyand, C. Is hypertension an immunologic disease? Curr. Cardiol. Rep. 10, 464-469 (2008).
23. Savoia, C. & Schiffrin, E.L. Inflammation in hypertension. Curr. Opin. Nephrol. Hypertens. 15, 152-158 (2006).
24. Shoelson, S.E., Lee, J. & Goldfine, A.B. Inflammation and insulin resistance. J. Clin. Invest. 116, 1793-1801 (2006). (Pubitemid 44033299)
25. Cai, D. NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle 8, 2542-2548 (2009).
26. Zhang, X. et al. Hypothalamic IKK/NF-B and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73 (2008).
27. Kleinridders, A. et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 10, 249-259 (2009).
28. Posey, K.A. et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab. 296, E1003-E1012 (2009).
29. Goncalves, A.C. et al. Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension 53, 387-392 (2009).
30. Hayden, M.S. & Ghosh, S. Shared principles in NF-B signaling. Cell 132, 344-362 (2008).
31. Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor B signaling. Immunol. Rev. 210, 171-186 (2006).
32. Vallabhapurapu, S. & Karin, M. Regulation and function of NF-B transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733 (2009).
33. Li, Q. & Verma, I.M. NF-B regulation in the immune system. Nat. Rev. Immunol. 2, 725-734 (2002).
34. Faustman, D. & Davis, M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat. Rev. Drug Discov. 9, 482-493 (2010).
35. Xu, A.W. et al. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 115, 951-958 (2005). (Pubitemid 40489399)
36. Kuo, J.J., da Silva, A.A., Tallam, L.S. & Hall, J.E. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension 43, 370-375 (2004). (Pubitemid 38174141)
37. Greenfield, J.R. et al. Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360, 44-52 (2009).
38. Tallam, L.S., Stec, D.E., Willis, M.A., da Silva, A.A. & Hall, J.E. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46, 326-332 (2005). (Pubitemid 41099165)
39. Farah, V.M., Joaquim, L.F., Bernatova, I. & Morris, M. Acute and chronic stress influence blood pressure variability in mice. Physiol. Behav. 83, 135-142 (2004). (Pubitemid 39387702)